An unusual association: Anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis

Clinical Rheumatology

Volumn 29, Issue 7, 2010, Pages 811-814

  Vincze, Melinda ^a   Molnár, Peter A ^a   Tumpek, Judit ^b   Szőllősi, Lászlóné ^b   Gyetvai, Ágnes ^b   Kapitány, Anikó ^b   Dankó, Katalin ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anti jo 1; Anti SRP; Interstitial lung disease; Polymyositis

Indexed keywords

ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; JO 1 ANTIBODY; METHYLPREDNISOLONE; SIGNAL RECOGNITION PARTICLE ANTIBODY; UNCLASSIFIED DRUG; AMINOACYL TRANSFER RNA; AUTOANTIBODY; SIGNAL RECOGNITION PARTICLE;

AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CHRONIC INFLAMMATION; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; HUMAN; LONG TERM CARE; MUSCLE WEAKNESS; MYALGIA; POLYMYOSITIS; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY;

AGED; AUTOANTIBODIES; FEMALE; HUMANS; POLYMYOSITIS; RNA, TRANSFER, AMINO ACYL; SIGNAL RECOGNITION PARTICLE;

EID: 77956263790     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1394-6     Document Type: Article

References (10)

1. Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatol 44:83-88
2. Leff RL, Burgess SH, Miller FW, Love A, Plotz PH (1988) Epidemiology of adult idiopathic inflammatory myopahy: A distinct clinical onset in patients with anti-Jo-1 antibodies. Arthritis Rheum 31: D113-S121
3. Lundberg I, Chung YL (2000) Treatment and investigation of idiopathic inflammatory myopathies. Rheumatol 39:7-17
4. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019-1038
5. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360-374
6. Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle:clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420-428
7. Hengstman GJ, ter Laak HJ, Vree Egberts WT (2006) Anti-signal recognition particle autoantibodies: marker of necrotising myopathy. Ann Rheum Dis 65:1635-1638
8. Miller FW (1991) Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 3:902-910
9. Lundberg IE, Grundtman C (2008) Developements in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 10:220
10. Czimbalmos Á, Nagy Zs, Varga Z, Husztik P (1999) Páciens megelégedettségi vizsgálat SF-36 kérdoívvel, a magyarországi normálértékek meghatá rozása. Népegészségügy 1:4-19